• / Free eNewsletters & Magazine
  • / My Account
Home>Finance>Food>Food And Drug Administration

Food And Drug Administration

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%

    Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%

  2. Guided Therapeutics Files PMA Amendment with FDA for LuViva® Advanced Cervical Scan

    Guided Therapeutics Files PMA Amendment with FDA for LuViva® Advanced Cervical Scan

  3. FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States

    FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States

  4. UPDATE: 10 things snack food companies won't tell you

    UPDATE: 10 things snack food companies won't tell you

  5. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014

    Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014

  6. InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2014

    InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2014

  7. SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 In STAAR Surgical Company To Contact The Firm Before The Lead Plaintiff Deadline In Class Action Lawsuit

    SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 In STAAR Surgical Company To Contact The Firm Before The Lead Plaintiff Deadline In Class Action Lawsuit

  8. Novogen And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™

    Novogen And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™

  9. Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer

    Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer

  10. IMRIS receives CE mark for integrating latest generation MR scanners within VISIUS Surgical Theatre in European market

    IMRIS receives CE mark for integrating latest generation MR scanners within VISIUS Surgical Theatre in European market

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.